Air pollution and biomarkers of systemic inflammation and tissue repair in COPD patients

European Respiratory Journal

Volumn 44, Issue 3, 2014, Pages 603-613

  Dadvand, Payam ^a,b   Nieuwenhuijsen, Mark J ^a,b   Agustí, Àlvar ^c,d,e   De Batlle, Jordi ^f   Benet, Marta ^a,b,g   Beelen, Rob ^h   Cirach, Marta ^a,b   Martinez, David ^a,b   Hoek, Gerard ^h   Basagaña, Xavier ^a,b   Ferrer, Antoni ^c,g,i   Ferrer, Jaume ^c,j   Rodriguez Roisin, Robert ^c,d   Sauleda, Jaume ^c,k,l   Guerra, Stefano ^a,b,g,m   Antó, Josep M ^a,b,g,n   Garcia Aymerich, Judith ^a,b,g  

^a CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e Fundació Investigació Sanitaria Illes Balears FISIB   (Spain)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^g UNIVERSITAT POMPEU FABRA   (Spain)

^h UTRECHT UNIVERSITY   (Netherlands)

ⁱ INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^j HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^k HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^l RediAPP   (Spain)

^m UNIVERSITY OF ARIZONA   (United States)

ⁿ HOSPITAL DEL MAR   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; INTERLEUKIN 8; NITROGEN DIOXIDE; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA; AIR POLLUTANT; PARTICULATE MATTER;

AGED; AIR POLLUTION; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; INFLAMMATION; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; PARTICULATE MATTER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SPAIN; SYSTEMIC DISEASE; TISSUE REPAIR; ADVERSE EFFECTS; AIR; AIR POLLUTANT; ANALYSIS; BLOOD; CHEMICALLY INDUCED; COHORT ANALYSIS; COMPLICATION; METABOLISM; METHODOLOGY; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; SMOKING;

AGED; AIR MOVEMENTS; AIR POLLUTANTS; AIR POLLUTION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; FIBRINOGEN; FORCED EXPIRATORY VOLUME; HEPATOCYTE GROWTH FACTOR; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; NITROGEN DIOXIDE; OBESITY; PARTICULATE MATTER; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESEARCH DESIGN; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907316702     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00168813     Document Type: Article

References (52)

1. Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574-580.
2. van Eeden SF, Yeung A, Quinlam K, et al. Systemic response to ambient particulate matter: relevance to chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 61-67.
3. Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: a result of "overspill" of inflammatory mediators from the lungs? Review of the evidence. Thorax 2010; 65: 930-936.
4. Agustí A, Edwards LD, Rennard SI, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 2012; 7: e37483.
5. Thomsen M, Ingebrigtsen TS, Marott JL, et al. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA 2013; 309: 2353-2361.
6. Man SF, Van Eeden S, Sin DD. Vascular risk in chronic obstructive pulmonary disease: role of inflammation and other mediators. Can J Cardiol 2012; 28: 653-661.
7. Ling SH, van Eeden SF. Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2009; 4: 233-243.
8. Li Y, Rittenhouse-Olson K, Scheider WL, et al. Effect of particulate matter air pollution on C-reactive protein: a review of epidemiologic studies. Rev Environ Health 2012; 27: 133-149.
9. Romieu I, Castro-Giner F, Kunzli N, et al. Air pollution, oxidative stress and dietary supplementation: a review. Eur Respir J 2008; 31: 179-197.
10. Dagouassat M, Lanone S, Boczkowski J. Interaction of matrix metalloproteinases with pulmonary pollutants. Eur Respir J 2012; 39: 1021-1032.
11. Rückerl R, Ibald-Mulli A, Koenig W, et al. Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med 2006; 173: 432-441.
12. Delfino RJ, Staimer N, Tjoa T, et al. Air pollution exposures and circulating biomarkers of effect in a susceptible population: clues to potential causal component mixtures and mechanisms. Environ Health Perspect 2009; 117:1232-1238.
13. Delfino RJ, Staimer N, Tjoa T, et al. Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ Health Perspect 2008; 116: 898-906.
14. Rückerl R, Greven S, Ljungman P, et al. Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors. Environ Health Perspect 2007; 115: 1072-1080.
15. Hildebrandt K, Rückerl R, Koenig W, et al. Short-term effects of air pollution: a panel study of blood markers in patients with chronic pulmonary disease. Part Fibre Toxicol 2009; 6: 25.
16. Peacock JL, Anderson HR, Bremner SA, et al. Outdoor air pollution and respiratory health in patients with COPD. Thorax 2011; 66: 591-596.
17. Mehta AJ, Schindler C, Perez L, et al. Acute respiratory health effects of urban air pollutants in adults with different patterns of underlying respiratory disease. Swiss Med Wkly 2012; 142: w13681.
18. Panganiban RA, Day RM. Hepatocyte growth factor in lung repair and pulmonary fibrosis. Acta Pharmacol Sin 2011; 32: 12-20.
19. Palange P, Testa U, Huertas A, et al. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur Respir J 2006; 27: 529-541.
20. Garcia-Aymerich J, Gómez FP, Antó JM, et al. Caracterizacion fenotipica y evolucion de la EPOC en el estudio PAC-COPD: diseno y metodologia [Phenotypic characterization and course of chronic obstructive pulmonary disease in the PAC-COPD Study: design and methods]. Arch Bronconeumol 2009; 45: 4-11.
21. Garcia-Aymerich J, Gómez FP, Benet M, et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 2011; 66: 430-437.
22. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
23. Roca J, Sanchis J, Agusti-Vidal A, et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 1986; 22: 217-224.
24. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol 1957; 17: 237-246.
25. Eeftens M, Beelen R, de Hoogh K, et al. Development of land use regression models for PM2.5, PM2.5 absorbance, PM10 and PMcoarse in 20 European study areas; results of the ESCAPE project. Environ Sci Technol 2012; 46: 11195-11205.
26. Beelen R, Hoek G, Vienneau D, et al. Development of NO2 and NOx land use regression models for estimating air pollution exposure in 36 study areas in Europe - the ESCAPE project. Atmos Environ 2013; 72: 10-23.
27. Panasevich S, Leander K, Rosenlund M, et al. Associations of long- and short-term air pollution exposure with markers of inflammation and coagulation in a population sample. Occup Environ Med 2009; 66: 747-753.
28. Donaire-Gonzalez D, Gimeno-Santos E, Serra I, et al. Validacion del cuestionario de actividad fisica de Yale en pacientes con enfermedad pulmonar obstructiva cronica [Validation of the Yale Physical Activity Survey in chronic obstructive pulmonary disease patients]. Arch Bronconeumol 2011; 47: 552-560.
29. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365.
30. Devalia JL, Campbell AM, Sapsford RJ, et al. Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol 1993; 9: 271-278.
31. Kienast K, McKinnon KP, Madden M, et al. In-vitro-Expositionen einer humanen bronchialen Epithelzelllinie mit Stickstoffdioxid induzieren eine vermehrte Transkription und Freisetzung proinflammatorischer Zytokine [In vitro exposure of a human bronchial epithelial cell line with nitrogen dioxide induces enhanced transcription and liberation of pro-inflammatory cytokines]. Pneumologie 1995; 49: 695-699.
32. Rich DQ, Kipen HM, Huang W, et al. Association between changes in air pollution levels during the Beijing Olympics and biomarkers of inflammation and thrombosis in healthy young adults. JAMA 2012; 307: 2068-2078.
33. Pekkanen J, Brunner EJ, Anderson HR, et al. Daily concentrations of air pollution and plasma fibrinogen in London. Occup Environ Med 2000; 57: 818-822.
34. Rudez G, Janssen NA, Kilinc E, et al. Effects of ambient air pollution on hemostasis and inflammation. Environ Health Perspect 2009; 117: 995-1001.
35. Kerr HD, Kulle TJ, McIlhany ML, et al. Effects of ozone on pulmonary function in normal subjects. An environmental-chamber study. Am Rev Respir Dis 1975; 111: 763-773.
36. Frampton MW, Morrow PE, Torres A, et al. Ozone responsiveness in smokers and nonsmokers. Am J Respir Crit Care Med 1997; 155: 116-121.
37. Frampton MW, Morrow PE, Torres A, et al. Effects of ozone on normal and potentially sensitive human subjects. Part II: Airway inflammation and responsiveness to ozone in nonsmokers and smokers. Res Rep Health Eff Inst 1997; 78: 39-72.
38. Rabinovitch N, Silveira L, Gelfand EW, et al. The response of children with asthma to ambient particulate is modified by tobacco smoke exposure. Am J Respir Crit Care Med 2011; 184: 1350-1357.
39. Baccarelli A, Kaufman JD. Ambient particulate air pollution, environmental tobacco smoking, and childhood asthma: interactions and biological mechanisms. Am J Respir Crit Care Med 2011; 184: 1325-1327.
40. Andersen ZJ, Hvidberg M, Jensen SS, et al. Chronic obstructive pulmonary disease and long-term exposure to traffic-related air pollution: a cohort study. Am J Respir Crit Care Med 2011; 183: 455-461.
41. Schikowski T, Sugiri D, Ranft U, et al. Long-term air pollution exposure and living close to busy roads are associated with COPD in women. Respir Res 2005; 6: 152.
42. Sunyer J, Jarvis D, Gotschi T, et al. Chronic bronchitis and urban air pollution in an international study. Occup Environ Med 2006; 63: 836-843.
43. Lindgren A, Stroh E, Montnemery P, et al. Traffic-related air pollution associated with prevalence of asthma and COPD/chronic bronchitis. A cross-sectional study in Southern Sweden. Int J Health Geogr 2009; 8: 2.
44. Xu X, Wang L. Synergistic effects of air pollution and personal smoking on adult pulmonary function. Arch Environ Health 1998; 53: 44-53.
45. Franssen FM, O'Donnell DE, Goossens GH, et al. Obesity and the lung: 5. Obesity and COPD. Thorax 2008; 63: 1110-1117.
46. Bridevaux PO, Gerbase MW, Schindler C, et al. Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2. Eur Respir J 2009; 34: 332-339.
47. Aryal S, Diaz-Guzman E, Mannino DM. COPD and gender differences: an update. Transl Res 2013; 162: 208-218.
48. Eeftens M, Beelen R, Fischer P, et al. Stability of measured and modelled spatial contrasts in NO2 over time. Occup Environ Med 2011; 68: 765-770.
49. Cesaroni G, Porta D, Badaloni C, et al. Nitrogen dioxide levels estimated from land use regression models several years apart and association with mortality in a large cohort study. Environ Health 2012; 11: 48.
50. Wang R, Henderson SB, Sbihi H, et al. Temporal stability of land use regression models for traffic-related air pollution. Atmos Environ 2013; 64: 312-319.
51. Gulliver J, de Hoogh K, Hansell A, et al. Development and back-extrapolation of NO2 land use regression models for historic exposure assessment in Great Britain. Environ Sci Technol 2013; 47: 7804-7811.
52. Agustí A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). Proc Am Thorac Soc 2007; 4: 522-525.